NCT05884437

Brief Summary

The purpose of this study is to assess the feasibility of our study procedures/protocols and to look at the potential effects of chiropractic care on people with metabolic syndrome.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 16, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

June 1, 2023

Completed
1.6 years until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 16, 2025

Completed
Last Updated

August 27, 2024

Status Verified

August 1, 2024

Enrollment Period

6 months

First QC Date

February 16, 2023

Last Update Submit

August 26, 2024

Conditions

Keywords

ChiropracticMetabolic syndromeSpinal manipulationautonomic nervous systemEEGpatient reported outcomes

Outcome Measures

Primary Outcomes (5)

  • Recruitment rate

    Length of time needed to recruit target number of participants

    through study completion, an average of 1 year

  • Participant adherence rate

    Proportion of participants able to adhere to the testing \& treatment schedule

    through study completion, an average of 1 year

  • Participant tolerability rate

    Proportion of participants able to perform all aspects of the testing regimen

    through study completion, an average of 1 year

  • Participant retention rate

    Proportion of enrolled participants who complete the full testing regimen

    through study completion, an average of 1 year

  • Acceptability of treatment regimen for participants

    9-item acceptability questionnaire

    Week 6

Secondary Outcomes (48)

  • EEG resting state broadband power

    Day 1

  • EEG resting state broadband power

    Week 2

  • EEG resting state broadband power

    Week 6

  • EEG resting state functional connectivity

    Day 1

  • EEG resting state functional connectivity

    Week 2

  • +43 more secondary outcomes

Study Arms (1)

Chiropractic

EXPERIMENTAL

Chiropractic adjustment

Procedure: Chiropractic adjustment

Interventions

Participants will receive 6 weeks of chiropractic care. The frequency of care will be determined by the field clinician. Participants will have their spine assessed for the presence of vertebral subluxations per their clinician's normal and customary procedures. The adjustment technique(s) utilized by the field clinician will be at their discretion.

Chiropractic

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Individuals over the age of 18
  • Individuals who can wear an EEG net for 30 minutes
  • Individuals who can sit quietly for at least 15 minutes
  • Individuals who can walk unassisted for up to 10 minutes
  • Individuals who can provide informed consent
  • Individuals who meet 3 of the 5 following criteria:
  • Elevated waist circumference (\>40 in/102 cm if male and \>35 in/88cm if female)
  • Elevated triglycerides (\>150 mg/dL) or drug treatment for elevated triglycerides
  • Reduced HDL-cholesterol (\<40mg/dL if male and \<50 mg/dL if female) or drug treatment to increase HDL-C
  • Elevated blood pressure (\>130 mm Hg systolic BP or \>85 mm Hg diastolic BP) or drug treatment to reduce blood pressure
  • Elevated fasting glucose (\>100 mg/dL) or drug treatment to reduce blood glucose

You may not qualify if:

  • Individuals with a known disorder resulting in syncope/fainting during postural changes (e.g., POTS, orthostatic hypotension)
  • Individuals with impaired function of the dominant hand
  • Individuals with malignant hypertension
  • Individuals with a known heart condition such as arrhythmia that results in an aberrant ECG recording
  • Individuals with any implanted devices (i.e., pacemakers)
  • Individuals with brain aneurysms
  • Individuals with a history of epilepsy or stroke that would influence EEG readings
  • Individuals with a diagnosed externalizing or thought disorder (i.e., anti-social disorder, any major personality disorder such as borderline personality disorder, or schizophrenia)
  • Individuals who are on short-acting benzodiazepines which include midazolam \& triazolam
  • Individuals with any serious injury or surgery to the head or torso, or lower body in the last 6 months
  • Individuals with a hearing impairment or hearing aids (due to the auditory stimulus recording being performed)
  • Individuals who are currently pregnant
  • Individuals with current litigation related to a physical, health-related injury
  • Individuals who have been diagnosed with rheumatoid arthritis, osteoporosis or instability of the neck.
  • Individuals with moderate to severe pain on a daily basis
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dr. Sid E. Williams Center for Chiropractic Research

Marietta, Georgia, 30067, United States

Location

MeSH Terms

Conditions

Metabolic Syndrome

Interventions

Manipulation, Chiropractic

Condition Hierarchy (Ancestors)

Insulin ResistanceHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Musculoskeletal ManipulationsComplementary TherapiesTherapeutics

Study Officials

  • Tyson Perez, DC, PhD

    Life University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Model Details: Single-arm pilot
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 16, 2023

First Posted

June 1, 2023

Study Start

January 1, 2025

Primary Completion

July 1, 2025

Study Completion

December 16, 2025

Last Updated

August 27, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations